Siltuximab-Related Favorable Clinical Outcome for a Patient Suffering from Idiopathic Multicentric Castleman Disease
RationalCastleman disease is a rare lymphoproliferative disorder that can be subdivided into unicentric and multicentric forms, the latter of which causes a spectrum of serious medical conditions. Here, we present a case of idiopathic multicentric Castleman disease in the eighth decade of life. Pati...
Saved in:
Main Authors: | Stamatios Chrysochoou, Andreas Kreft, Eberhard Schneider |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-01-01
|
Series: | Case Reports in Hematology |
Online Access: | http://dx.doi.org/10.1155/2022/1840589 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Multicentric Castleman’s Disease, Associated with Idiopathic Thrombocytopenic Purpura
by: Ruchi Sood, et al.
Published: (2013-01-01) -
Idiopathic multicentric Castleman disease in children: a single-center retrospective analysis
by: Junye Du, et al.
Published: (2025-01-01) -
Idiopathic Multicentric Castleman Disease following SARS-CoV-2 Vaccination
by: Chien-Yu Ker, et al.
Published: (2023-07-01) -
Chronic Myelomonocytic Leukemia following Multicentric Castleman Disease
by: Feng Li, et al.
Published: (2018-01-01) -
Multicentric Castleman’s Disease in a Child Revealed by Chronic Diarrhea
by: Sarra Benmiloud, et al.
Published: (2015-01-01)